Position in CASIF
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$17
-$199 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CASIF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $58,541 across 13 Biotechnology names. CASIF ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $15,588 | |
| 2 | INSM |
INSMED Inc
|
98 | $10,448 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
153 | $8,344 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12 | $5,960 | |
| 5 | ABVX |
Abivax S.A.
|
41 | $5,463 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
50 | $4,078 | |
| 7 | BLTE |
Belite Bio, Inc
|
18 | $2,771 | |
| 8 | QURE |
uniQure N.V.
|
59 | $2,717 |
All Filings in CASIF
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17 | 100 | Shares | Sole | 2026-07-20 | |
| 2025-03-31 | $216 | 100 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $283 | 100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $616 | 100 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $550 | 100 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $361 | 100 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $716 | 100 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $256 | 100 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $250 | 100 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $232 | 100 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $179 | 100 | Shares | Sole | 2023-12-18 | |
| No filing history on record for this holder in this stock. | ||||||